-transparent.png){kind=logo}
Newly diagnosed patients of pulmonary tuberculosis (n = 112) were put on a rifampicin-containing drug regimen. Fifty six patients were also given a placebo tablet twice daily while the other fifty-six were given ranitidine 150 mg twice daily. Gastric pH, gastric emptying time, serum rifampicin levels, urinary total and unchanged rifampicin, serum bilirubin and ALT levels were measured serially. Clinical record of adverse symptoms was maintained. Ranitidine increased the basal as well as post-drug gastric pH without altering the gastric emptying time. Concomitant administration of ranitidine and rifampicin did not alter the absorption, metabolism or excretion of the latter but reduced the frequency of gastrointestinal symptoms.
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
April 1990,
Cardiovascular drugs and therapy,
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
August 1984,
Deutsche medizinische Wochenschrift (1946),
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
January 1990,
Annals of internal medicine,
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
May 1994,
Annals of internal medicine,
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
February 1988,
Canadian family physician Medecin de famille canadien,
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
January 1982,
The Medical journal of Australia,
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
October 1979,
British journal of diseases of the chest,
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
May 1995,
Revista clinica espanola,
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
August 1984,
Annals of internal medicine,
S D Purohit, and
S C Johri, and
P R Gupta, and
Y R Mehta, and
M Bhatnagar
April 1986,
Drug intelligence & clinical pharmacy,
